Recruiting at 1 site No phase Gastroparesis

Gastroparesis study: Gastric Alimetry System

Official title The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM

ClinicalTrials.gov ID: NCT06493032

What this study is testing

What it's testing
This study is testing whether body surface gastric mapping can show who will benefit from the G‑POEM procedure in people with gastroparesis.
Who it's for
You may be able to join if you have gastroparesis symptoms.
What's involved
You will have a non‑invasive stomach mapping test done on your skin. You may also have a few check‑in visits after the test.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients clinically eligible for G-Poem at our center.

You likely can't join if

  • Pregnant or breast-feeding
  • Patients with gastroparesis due to spinal cord injuries due to difficulties in conducting the BSGM.
  • Inability to perform BSGM: history of severe skin allergies or sensitivity to cosmetics or lotions
  • Patients with abdominal drains or tubes

The study team makes the final eligibility decision.

Where it is enrolling

  • Indianapolis, Indiana, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Indianapolis, Indiana, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.